IGC Pharma, Inc.
IGC
$0.4637
$0.073718.90%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.61% | 28.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.61% | 28.40% | |||
| Cost of Revenue | -1.14% | 15.03% | |||
| Gross Profit | 0.00% | 48.08% | |||
| SG&A Expenses | 94.67% | -45.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 24.44% | -16.07% | |||
| Operating Income | -30.10% | 22.15% | |||
| Income Before Tax | -33.58% | 34.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -33.58% | 34.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -33.58% | 34.55% | |||
| EBIT | -30.10% | 22.15% | |||
| EBITDA | -34.63% | 24.00% | |||
| EPS Basic | -28.67% | 36.44% | |||
| Normalized Basic EPS | -20.00% | 31.97% | |||
| EPS Diluted | -28.67% | 36.44% | |||
| Normalized Diluted EPS | -20.00% | 31.97% | |||
| Average Basic Shares Outstanding | 4.32% | 2.52% | |||
| Average Diluted Shares Outstanding | 4.32% | 2.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||